Last 12 months
Inside the activity.
2 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 2 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 27, 2025 Filed Jan 30, 2025 01:56 UTC |
BAKKEN SCOTTVP, Regulatory Affairs
|
Tax withholdingCommon Shares | 6,253 | $5.17 | $32,328.01 |
DisclosureSEC source: 0000912282-25-000065 · form4.xml · nonDerivative · entry 1 BAKKEN SCOTT · CIK 0001823094 · VP, Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,632 Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:02 UTC |
BONIFAS BERNARDVP, ISR Operations
|
Tax withholdingCommon Shares | 4,038 | $5.17 | $20,876.46 |
DisclosureSEC source: 0000912282-25-000069 · form4.xml · nonDerivative · entry 1 BONIFAS BERNARD · CIK 0001989558 · VP, ISR Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,067 Read SEC document |
| January 02, 2025 Filed Jan 29, 2025 20:45 UTC |
Bovaird J. BirksDirector
|
SaleCommon Shares | 10,000 | $5.44 | $54,400.00 |
DisclosureSEC source: 0000912282-25-000063 · form4.xml · nonDerivative · entry 1 Bovaird J. Birks · CIK 0001662181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,380 F1 · price: Converted from Canadian sale price of $7.85 using an exchange rate of C$1.4418 = US$1.00. Read SEC document |
| December 18, 2024 Filed Dec 18, 2024 15:54 UTC |
Morrison Alex GDirector
|
SaleCommon Shares | 17,500 | $5.72 | $100,024.75 |
DisclosureSEC source: 0001385849-24-000054 · primary_doc.xml · nonDerivative · entry 1 Morrison Alex G · CIK 0001562603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,528 Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 17:50 UTC |
DRERA SALEEMVP Radioisotopes, Radiological · Systems & IP
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 1,863 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001345 · form4.xml · derivative · entry 2 DRERA SALEEM · CIK 0002035000 · VP Radioisotopes, Radiological · Systems & IP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,863 Underlying: Common Shares · 1,863 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects grant of 1,863 options having a strike price at a 10% premium of the grant price of $6.59, which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 17:50 UTC |
DRERA SALEEMVP Radioisotopes, Radiological · Systems & IP
|
GrantCommon Shares | 1,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001345 · form4.xml · nonDerivative · entry 1 DRERA SALEEM · CIK 0002035000 · VP Radioisotopes, Radiological · Systems & IP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,094 F1 · shares: Reflects grant of 1,620 RSUs which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:44 UTC |
LONGENECKER NATHANSr VP and General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,583 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001342 · form4.xml · derivative · entry 2 LONGENECKER NATHAN · CIK 0002033958 · Sr VP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,583 Underlying: Common Shares · 6,583 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects grant of 6,583 options having a strike price at a 10% premium of the grant price of $6.59, which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:44 UTC |
LONGENECKER NATHANSr VP and General Counsel
|
GrantCommon Shares | 5,722 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001342 · form4.xml · nonDerivative · entry 1 LONGENECKER NATHAN · CIK 0002033958 · Sr VP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,638 F1 · shares: Represents grant of 5,722 restricted stock units which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 17:55 UTC |
Bennett Nathan ReedCAO & Interim CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 10,465 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001348 · form4.xml · derivative · entry 2 Bennett Nathan Reed · CIK 0002006665 · CAO & Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,465 Underlying: Common Shares · 10,465 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects grant of 10,465 options having a strike price at a 10% premium of the grant price of $6.59, which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 17:55 UTC |
Bennett Nathan ReedCAO & Interim CFO
|
GrantCommon Shares | 9,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001348 · form4.xml · nonDerivative · entry 1 Bennett Nathan Reed · CIK 0002006665 · CAO & Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,185 F1 · shares: Reflects grant of 9,096 restricted stock units which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:48 UTC |
Chalmers MarkDirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 21,970 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001344 · form4.xml · derivative · entry 2 Chalmers Mark · CIK 0001678867 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,970 Underlying: Common Shares · 21,970 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects grant of 21,970 options having a strike price at a 10% premium of the grant price of $6.59 which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:48 UTC |
Chalmers MarkDirector · President & CEO
|
GrantCommon Shares | 19,096 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001344 · form4.xml · nonDerivative · entry 1 Chalmers Mark · CIK 0001678867 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 930,439 F1 · shares: Reflects grant of 19,096 RSUs which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:46 UTC |
Frydenlund David C.EVP & Chief Legal Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 13,142 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001343 · form4.xml · derivative · entry 2 Frydenlund David C. · CIK 0001662034 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,142 Underlying: Common Shares · 13,142 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects grant of 13,142 options having a strike price at a 10% premium of the grant price of $6.59, which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:46 UTC |
Frydenlund David C.EVP & Chief Legal Officer
|
GrantCommon Shares | 11,423 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001343 · form4.xml · nonDerivative · entry 1 Frydenlund David C. · CIK 0001662034 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 642,071 F1 · shares: Reflects grant of 11,423 RSUs which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:42 UTC |
Moore CurtisSVP Marketing/Corp Development
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,528 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001341 · form4.xml · derivative · entry 2 Moore Curtis · CIK 0001662070 · SVP Marketing/Corp Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,528 Underlying: Common Shares · 9,528 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects a grant of 9,528 options having a strike price at a 10% premium of the grant price of $6.59, which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:42 UTC |
Moore CurtisSVP Marketing/Corp Development
|
GrantCommon Shares | 8,281 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001341 · form4.xml · nonDerivative · entry 1 Moore Curtis · CIK 0001662070 · SVP Marketing/Corp Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,474 F1 · shares: Represents grant of 8,281 restricted stock units which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:41 UTC |
SHUMWAY LOGANVP, Processing Operations
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,558 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001340 · form4.xml · derivative · entry 2 SHUMWAY LOGAN · CIK 0001989978 · VP, Processing Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,558 Underlying: Common Shares · 8,558 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects grant of 8,558 options having a strike price at a 10% premium of the grant price of $6.59, which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:41 UTC |
SHUMWAY LOGANVP, Processing Operations
|
GrantCommon Shares | 7,439 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001340 · form4.xml · nonDerivative · entry 1 SHUMWAY LOGAN · CIK 0001989978 · VP, Processing Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,115 F1 · shares: Represents grant of 7,439 restricted stock units which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:35 UTC |
BONIFAS BERNARDVP, ISR Operations
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 5,590 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001337 · form4.xml · derivative · entry 2 BONIFAS BERNARD · CIK 0001989558 · VP, ISR Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,590 Underlying: Common Shares · 5,590 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects grant of 5,590 options having a strike price at a 10% premium of the grant price of $6.59, which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:35 UTC |
BONIFAS BERNARDVP, ISR Operations
|
GrantCommon Shares | 4,859 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001337 · form4.xml · nonDerivative · entry 1 BONIFAS BERNARD · CIK 0001989558 · VP, ISR Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,051 F1 · shares: Reflects grant of 4,859 restricted stock units which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:39 UTC |
BAKKEN SCOTTVP, Regulatory Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,037 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001339 · form4.xml · derivative · entry 2 BAKKEN SCOTT · CIK 0001823094 · VP, Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,037 Underlying: Common Shares · 6,037 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects grant of 6,037 options having a strike price at a 10% premium of the grant price of $6.59, which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:39 UTC |
BAKKEN SCOTTVP, Regulatory Affairs
|
GrantCommon Shares | 5,248 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001339 · form4.xml · nonDerivative · entry 1 BAKKEN SCOTT · CIK 0001823094 · VP, Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,065 F1 · shares: Reflects grant of 5,248 restricted stock units which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:20 UTC |
KAPOSTASY DANIELVP, Technical Services
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,352 | $0.00 Strike: $7.25 | $0.00 |
DisclosureSEC source: 0000912282-25-001335 · form4.xml · derivative · entry 2 KAPOSTASY DANIEL · CIK 0001989355 · VP, Technical Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,352 Underlying: Common Shares · 8,352 shares Expires 2029-12-11 F2 · derivative.exercise_date: Reflects grant of 8,352 options having a strike price at a 10% premium of the grant price of $6.59, which vest as follows: 50% on 12/12/2025 and 50% on 12/12/2026. Read SEC document |
| December 12, 2024 Filed Dec 1, 2025 22:20 UTC |
KAPOSTASY DANIELVP, Technical Services
|
GrantCommon Shares | 7,260 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001335 · form4.xml · nonDerivative · entry 1 KAPOSTASY DANIEL · CIK 0001989355 · VP, Technical Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,965 F1 · shares: Reflects grant of 7,260 RSUs which vest as follows: 50% on 1/27/2025; 25% on 1/27/2026; and 25% on 1/27/2027. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 14:47 UTC |
HIGGS DENNIS LYLEDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,615 | $0.00 Strike: $4.48 | $0.00 |
DisclosureSEC source: 0001385849-24-000053 · primary_doc.xml · derivative · entry 3 HIGGS DENNIS LYLE · CIK 0001134878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 18,615 shares Expires 2025-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 14:47 UTC |
HIGGS DENNIS LYLEDirector
|
SaleCommon Shares | 18,615 | $7.23 | $134,634.85 |
DisclosureSEC source: 0001385849-24-000053 · primary_doc.xml · nonDerivative · entry 2 HIGGS DENNIS LYLE · CIK 0001134878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,422 Read SEC document |
| November 19, 2024 Filed Nov 21, 2024 14:47 UTC |
HIGGS DENNIS LYLEDirector
|
Exercise / conversionCommon Shares | 18,615 | $4.48 | $83,395.20 |
DisclosureSEC source: 0001385849-24-000053 · primary_doc.xml · nonDerivative · entry 1 HIGGS DENNIS LYLE · CIK 0001134878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 18:46 UTC |
SHUMWAY LOGANVP, Processing Operations
|
PurchaseCommon Shares | 1,500 | $5.39 | $8,085.00 |
DisclosureSEC source: 0001385849-24-000049 · primary_doc.xml · nonDerivative · entry 1 SHUMWAY LOGAN · CIK 0001989978 · VP, Processing Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,615 Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 18:29 UTC |
STIRZAKER MICHAELDirector
|
GrantCommon Shares | 4,674 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-24-000691 · form4.xml · nonDerivative · entry 1 STIRZAKER MICHAEL · CIK 0002040273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,674 F1 · balance_after: The directly held securities reported in Table I are comprised of 4,674 restricted stock units granted to Mr. Stirzaker in connection with his appointment as a new director of Issuer, which vest as follows: 50% on January 27, 2025; 25% on January 27, 2026, and 25% on January 27, 2027 (U.S.). Read SEC document |
| August 19, 2024 Filed Aug 23, 2024 20:24 UTC |
DRERA SALEEMVP Radioisotopes, Radiological · Systems & IP
|
GrantPerformance-Based Stock Options ("Options") · Derivative | 7,506 | $0.00 Strike: $5.09 | $0.00 |
DisclosureSEC source: 0000912282-24-000595 · form4.xml · derivative · entry 2 DRERA SALEEM · CIK 0002035000 · VP Radioisotopes, Radiological · Systems & IP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,506 Underlying: Common Shares · 7,506 shares Expires 2029-08-18 F2 · shares: The amount reported in Table II, Section 5 represents 7,506 unvested Options granted to Reporting Person by the Issuer with a strike price at a 10% premium of the grant price of $4.65, effective as of August 19, 2024 and vesting as follows: 50% on 08/19/2025; and 50% on 08/19/2026. The grant has a term of five years. Read SEC document |
| August 19, 2024 Filed Aug 23, 2024 20:24 UTC |
DRERA SALEEMVP Radioisotopes, Radiological · Systems & IP
|
GrantCommon Shares | 6,811 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-24-000595 · form4.xml · nonDerivative · entry 1 DRERA SALEEM · CIK 0002035000 · VP Radioisotopes, Radiological · Systems & IP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,406 F1 · balance_after: The amount reported in Table I, Section 4 represents 266,595 restricted Common Shares previously granted to Reporting Person by the Issuer in partial consideration for Issuer's acquisition of RadTran, LLC on 08/16/2024, and 6,811 unvested restricted stock units ("RSUs") granted to Reporting Person by the Issuer, effective as of August 19, 2024 and vesting as follows: 50% on 01/27/2025; 25% on 01/27/2026; and 25% on 01/27/2027. Read SEC document |
| August 09, 2024 Filed Aug 16, 2024 15:56 UTC |
LONGENECKER NATHANSr VP and General Counsel
|
GrantPerformance-Based Stock Options ("Options") · Derivative | 27,505 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0000912282-24-000572 · form4.xml · derivative · entry 2 LONGENECKER NATHAN · CIK 0002033958 · Sr VP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,505 Underlying: Common Shares · 27,505 shares Expires 2029-08-08 F2 · shares: The amount reported in Table II, Section 5 represents 27,505 unvested Options granted to Reporting Person by the Issuer with a strike price at a 10% premium of the grant price of $4.69, effective as of August 9, 2024 and vesting as follows: 50% on 08/09/2025; and 50% on 08/09/2026. The grant has a term of five years. Read SEC document |
| August 09, 2024 Filed Aug 16, 2024 15:56 UTC |
LONGENECKER NATHANSr VP and General Counsel
|
GrantCommon Shares | 23,840 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-24-000572 · form4.xml · nonDerivative · entry 1 LONGENECKER NATHAN · CIK 0002033958 · Sr VP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,840 F1 · shares: The amount reported in Table I, Section 4 represents 23,840 unvested restricted stock units ("RSUs") granted to Reporting Person by the Issuer, effective as of August 9, 2024 and vesting as follows: 50% on 1/27/2025; 25% on 01/27/2026; and 25% on 01/27/2027. Read SEC document |
| May 13, 2024 Filed May 14, 2024 18:42 UTC |
HERRERA JAQUELINEDirector
|
PurchaseCommon Shares | 2,584 | $6.20 | $16,020.80 |
DisclosureSEC source: 0001385849-24-000044 · primary_doc.xml · nonDerivative · entry 2 HERRERA JAQUELINE · CIK 0001932289 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,998 Read SEC document |
| May 10, 2024 Filed May 14, 2024 18:42 UTC |
HERRERA JAQUELINEDirector
|
PurchaseCommon Shares | 1,395 | $6.09 | $8,495.55 |
DisclosureSEC source: 0001385849-24-000044 · primary_doc.xml · nonDerivative · entry 1 HERRERA JAQUELINE · CIK 0001932289 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,414 Read SEC document |
| May 08, 2024 Filed May 9, 2024 11:39 UTC |
Bennett Nathan ReedCAO / Interim CFO
|
PurchaseCommon Shares | 1,500 | $5.88 | $8,820.00 |
DisclosureSEC source: 0001385849-24-000043 · primary_doc.xml · nonDerivative · entry 1 Bennett Nathan Reed · CIK 0002006665 · CAO / Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,012 Read SEC document |
| May 07, 2024 Filed May 7, 2024 16:16 UTC |
ESTABROOKE IVYDirector
|
PurchaseCommon Shares | 1,740 | $5.76 | $10,022.40 |
DisclosureSEC source: 0001385849-24-000032 · primary_doc.xml · nonDerivative · entry 1 ESTABROOKE IVY · CIK 0001908813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,284 Read SEC document |
| May 07, 2024 Filed May 7, 2024 21:25 UTC |
HANSEN BRUCE DDirector
|
PurchaseCommon Shares | 6,000 | $5.83 | $34,950.00 |
DisclosureSEC source: 0001385849-24-000040 · primary_doc.xml · nonDerivative · entry 1 HANSEN BRUCE D · CIK 0001064614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,380 Read SEC document |
| May 07, 2024 Filed May 7, 2024 12:26 UTC |
Bovaird J. BirksDirector
|
PurchaseCommon Shares | 1,000 | $7.85 | $7,850.00 |
DisclosureSEC source: 0001385849-24-000034 · primary_doc.xml · nonDerivative · entry 1 Bovaird J. Birks · CIK 0001662181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,380 Read SEC document |
| May 07, 2024 Filed May 7, 2024 12:12 UTC |
Morrison Alex GDirector
|
PurchaseCommon Shares | 1,600 | $5.78 | $9,241.60 |
DisclosureSEC source: 0001385849-24-000031 · primary_doc.xml · nonDerivative · entry 1 Morrison Alex G · CIK 0001562603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,028 Read SEC document |
| May 07, 2024 Filed May 7, 2024 13:08 UTC |
Filas Barbara AppelinDirector
|
PurchaseCommon Shares | 1,700 | $5.78 | $9,824.64 |
DisclosureSEC source: 0001385849-24-000036 · primary_doc.xml · nonDerivative · entry 1 Filas Barbara Appelin · CIK 0001455291 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,660 Read SEC document |
| May 07, 2024 Filed May 7, 2024 20:32 UTC |
SHUMWAY LOGANVP Conventional Operations
|
PurchaseCommon Shares | 4,000 | $5.84 | $23,360.00 |
DisclosureSEC source: 0001385849-24-000039 · primary_doc.xml · nonDerivative · entry 1 SHUMWAY LOGAN · CIK 0001989978 · VP Conventional Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,115 Read SEC document |
| May 07, 2024 Filed May 7, 2024 18:54 UTC |
Chalmers MarkDirector · President & CEO
|
PurchaseCommon Shares | 16,838 | $5.86 | $98,670.68 |
DisclosureSEC source: 0001385849-24-000038 · primary_doc.xml · nonDerivative · entry 1 Chalmers Mark · CIK 0001678867 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 940,673 Read SEC document |
| May 07, 2024 Filed May 7, 2024 17:13 UTC |
Frydenlund David C.Executive VP, CLO and · Corporate Secretary
|
PurchaseCommon Shares | 834 | $5.86 | $4,887.24 |
DisclosureSEC source: 0001385849-24-000037 · primary_doc.xml · nonDerivative · entry 1 Frydenlund David C. · CIK 0001662034 · Executive VP, CLO and · Corporate Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 557,501 Read SEC document |
| May 07, 2024 Filed May 7, 2024 16:30 UTC |
NAZARENUS DEE ANNVP Human Resources and · Administration
|
PurchaseCommon Shares | 164 | $5.87 | $961.86 |
DisclosureSEC source: 0001385849-24-000035 · primary_doc.xml · nonDerivative · entry 1 NAZARENUS DEE ANN · CIK 0001822944 · VP Human Resources and · Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,804 Read SEC document |
| May 07, 2024 Filed May 7, 2024 16:21 UTC |
KAPOSTASY DANIELVP Technical Services
|
PurchaseCommon Shares | 1,015 | $5.90 | $5,984.44 |
DisclosureSEC source: 0001385849-24-000033 · primary_doc.xml · nonDerivative · entry 1 KAPOSTASY DANIEL · CIK 0001989355 · VP Technical Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,417 Read SEC document |
| May 07, 2024 Filed May 8, 2024 18:59 UTC |
Kirkwood Robert W.Director
|
PurchaseCommon Shares | 17,200 | $5.84 | $100,430.80 |
DisclosureSEC source: 0001385849-24-000041 · primary_doc.xml · nonDerivative · entry 2 Kirkwood Robert W. · CIK 0001706990 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Kirkwood Son Trust #2 Disclosed balance after: 228,475 Read SEC document |
| May 07, 2024 Filed May 8, 2024 18:59 UTC |
Kirkwood Robert W.Director
|
PurchaseCommon Shares | 8,550 | $5.84 | $49,906.35 |
DisclosureSEC source: 0001385849-24-000041 · primary_doc.xml · nonDerivative · entry 1 Kirkwood Robert W. · CIK 0001706990 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,912 Read SEC document |
| May 07, 2024 Filed May 8, 2024 23:02 UTC |
Eshleman Benjamin IIIDirector
|
PurchaseCommon Shares | 5,000 | $5.92 | $29,600.00 |
DisclosureSEC source: 0001385849-24-000042 · primary_doc.xml · nonDerivative · entry 1 Eshleman Benjamin III · CIK 0001707162 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,642 Read SEC document |
| May 07, 2024 Filed May 9, 2024 19:18 UTC Amendment |
Bovaird J. BirksDirector
|
PurchaseCommon Shares | 1,000 | $5.73 | $5,730.00 |
DisclosureSEC source: 0000912282-24-000433 · form4.xml · nonDerivative · entry 1 Bovaird J. Birks · CIK 0001662181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,380 F1 · kind: The reporting person's purchase of UUUU common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 1,000 shares, with the reporting person's sale of 6,000 shares of UUUU common stock at a price of $8.38, converted from Canadian sale price of $11.50 using an exchange rate of C$1.3722 = US$1.00, on November 17, 2023. The reporting person has agreed to pay to Energy Fuels Inc., upon settlement of the purchase, $2,652.87, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs. F2 · price: Converted from Canadian purchase price of C$7.85 using an exchange rate of C$1.3705 = US$1.00. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.